Larimar Therapeutics Reports First Quarter 2021 Operating and Financial Results

Go back to Larimar Therapeutics Reports First Quarter 2021 Operating and Financial Results
(NASDAQ: LRMR) Delayed: 4.20 +0.10 (2.44%)
Previous Close $4.10    52 Week High
Open $4.19    52 Week Low
Day High $4.31    P/E N/A 
Day Low $4.14    EPS
Volume 759,355